• Study of Platelet-Rich Plasma Injections Combined with Exercise Compared to Betamethasone and Ropivacaine for Chronic Shoulder Pain Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain

  • Study of methadone and morphine combination for pain relief in patients with bone metastases from cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments

    Recruiting

    1 1 1
    Investigated Drugs:
    Belgium Germany Italy Spain

  • Study of IMVT-1402 Treatment for Adults with Graves’ Disease

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Greece Italy Latvia +3

  • Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Bulgaria Croatia Czechia Germany Italy +2

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Greece Norway Spain

  • Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

    Recruiting

    2 1
    Investigated Drugs:
    Bulgaria Czechia Hungary Poland Slovakia

  • Study of nirsevimab and RSV vaccine (Abrysvo) for prevention of respiratory syncytial virus infection in infants during their first year of life

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Italy Spain

powered by